Wesley Edens
Analyst · Sterne Agee
Great, thanks Sarah and welcome everyone. Let me just give a few introductory remarks and I’ll turn over to the other folks to speak. The quarter we just finished is a very good one, GAAP income $63 million, $0.24 per share; core earnings $38 million, $0.15 per share; uninvested cash on average over the quarter was just about a $100 million. So had that cash been invested, our core earnings would have been about $0.01 or $0.02 higher. We declared the common dividend of $44 million or $0.175 per share. One of the questions, I am sure that folks have is that obviously given the difference between GAAP earnings and common dividend our anticipation is we’ll have some kind of a top up dividend at the end of the year. Our taxable income is in between the two, right because we don’t pay, some of the GAAP income is not a taxable event and we have to pay out 100% of our tax income. So it’s probably a few cents differential but Jon Brown will talk about that when he goes through the remarks in his segment.
So I am going to refer to the supplement that we posted here recently. So just starting with Page 4, investment highlights for the quarter, we funded approximately $250 million of investments throughout the quarter, generated over $140 million of cash free investment from the existing portfolio, the excess MSR investments which are about 1/2 of our capital, we invested $216 million including $198 million to fund, previously committed investments and then another one small investment of $18 million to acquire 40% interest in another excess MSR related to a $5 billion pool of non-agency loans.
The performance of those investments has been terrific. We are very optimistic about their prospects going forward, when I get to the investment part of it actually Mike Nierenberg is with us here this morning will talk about that a little bit.
The consumer side, also a very good quarter. Just to refresh the numbers a little bit, we invested a total of $241 million in capital into this portfolio of loans that is also invested in and serviced by Springleaf which is one of our sister company here at Fortress. During the quarter we sold down a piece of subordinate financing to reduce our capital, so our capital in the investment went from $241 million down to $133 million. The performance of that portfolio has been terrific. When we bought it we were estimating an unleveraged return on the portfolio of low double digits, about 11%. It looks like the current performance of it is actually mid double digits so about 15%. So with 80% financing at 3 ¾% on an unleveraged investment of 15% it is a terrific investment. I think our current estimate is it will end up being something between 35% and 40% returns. So it’s been a terrific investment, we took out a chunk of capital and did so at very good rates on that.
On the non-agency side, a very active quarter. We sold and bought securities. Mike will talk about specifically in terms of what our thoughts about that, but we are always looking for opportunities to harvest what we think are more mature investments and invest in things that we think have more upside and so that generated some gains for us for the quarter.
Page 5, subsequent to the quarter end, we invested or committed to an additional $200 million, so again a very, very busy quarter. One thing I would say just generally speaking is that although the markets have gotten increasingly competitive in a number of our core products, these are very, very large markets and we think that there is lots of interesting things to do. So excess MSR investments, obviously non-agency which we talked about. The last thing on the list non-performing loans, we made our first investment in that sector, that is something we think is going to be a very active sector in the market, generally and we do think that there is going to some good opportunities there.
Page 6 just if you look at the business snapshot and you can add it up by capital. So excess MSRs $667 million of the $1.2 billion in total capital. Obviously the non-agency is a big investment for us, we have our consumer loans and then we had a bunch of cash on balance sheet at the end of the year. Our expected life time returns on the portfolio is just under 20%, on the portfolio that is actually quite under leveraged. So we think that that’s a great profile and responsible for a lot of the other terrific results we had.
The potential for growth, in terms of these different products, excess MSRs, non-agencies, the non-performing mortgage loans and other investments is something I'll hold that dialog till the end. I think it's safe to say that there still there is lots and lots of interesting opportunities out there.
So, with that let me take a pause and turn it over to Mike Nierenberg to go through the portfolios. Mike?